MDVNX
Price
$10.15
Change
+$0.05 (+0.50%)
Updated
Jul 3 closing price
Net Assets
339.94M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

MDVNX vs VVIAX

Header iconMDVNX vs VVIAX Comparison
Open Charts MDVNX vs VVIAXBanner chart's image
MassMutual Diversified Value R3
Price$10.15
Change+$0.05 (+0.50%)
VolumeN/A
Net Assets339.94M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
MDVNX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MDVNX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDVNX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. MDVNX (340M). VVIAX pays higher dividends than MDVNX: VVIAX (2.18) vs MDVNX (1.32). MDVNX was incepted earlier than VVIAX: MDVNX (21 years) vs VVIAX (25 years). MDVNX (1.34) is less costly to investors than VVIAX (0.05). MDVNX is a more actively managed with annual turnover of: 46.00 vs. VVIAX (9.00). MDVNX has a lower initial minimum investment than VVIAX: MDVNX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. MDVNX (-16.22). VVIAX return over 5 years is better than : 80.13 vs. MDVNX (14.66).
MDVNXVVIAXMDVNX / VVIAX
Total Expense Ratio1.340.052,680%
Annual Report Gross Expense Ratio1.340.052,680%
Fund Existence21 years25 years-
Gain YTD7.4076.198120%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets340M189B0%
Annual Yield % from dividends1.322.1860%
Returns for 1 year-16.2212.03-135%
Returns for 3 years-8.8435.17-25%
Returns for 5 years14.6680.1318%
Returns for 10 years-21.18115.67-18%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.